| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ |
|---|---|---|---|---|---|---|
| Revenue | $2.4B | $2.4B | $2.4B | $1.3B | $0.1B | $0.1B |
| Cost of Revenue | $1.1B | $0.9B | $1.0B | $0.6B | $0.3B | $0.2B |
| Gross Profit | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — |
| SG&A Expense | $0.3B | $0.2B | $0.2B | $0.2B | $0.1B | $0.2B |
| Operating Income | $0.5B | $0.9B | $0.7B | $0.2B | $0.0B | $-0.0B |
| Net Income | $-0.2B | $0.5B | $0.2B | $0.1B | $0.0B | $-0.0B |
| EPS (Basic) | $-1.24 | $2.66 | $0.93 | $0.49 | — | — |
| EPS (Diluted) | $-1.25 | $2.65 | $0.93 | $0.47 | — | — |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ |
|---|---|---|---|---|---|---|
| Total Assets | $12.9B | $10.5B | $7.7B | $6.9B | $1.9B | $1.1B |
| Current Assets | $1.6B | $1.0B | $1.4B | $0.6B | $0.8B | $0.2B |
| Cash & Equivalents | $0.5B | $0.2B | $0.7B | $0.2B | $0.6B | $0.0B |
| Total Liabilities | $10.8B | $8.7B | $6.3B | $4.9B | $1.5B | $0.7B |
| Current Liabilities | $1.7B | $1.7B | $1.4B | $0.6B | $0.2B | $0.1B |
| Stockholders' Equity | $1.9B | $1.6B | $1.3B | $1.8B | $0.4B | $0.1B |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ |
|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.6B | $0.8B | $0.4B | $0.1B | $-0.1B | $-0.2B |
| Investing Cash Flow | $-2.1B | $-2.9B | $-0.1B | $-2.3B | $-0.2B | $-0.4B |
| Capital Expenditures | $2.6B | $3.0B | $1.2B | $0.7B | $0.2B | $0.4B |
| Financing Cash Flow | $2.2B | $1.5B | $0.3B | $1.8B | $0.8B | $0.6B |